scholarly journals Altered functional connectivity in binge eating disorder and bulimia nervosa: A resting-state fMRI study

2019 ◽  
Vol 9 (2) ◽  
pp. e01207 ◽  
Author(s):  
Marion A. Stopyra ◽  
Joe J. Simon ◽  
Mandy Skunde ◽  
Stephan Walther ◽  
Martin Bendszus ◽  
...  
2015 ◽  
Vol 607 ◽  
pp. 120-124 ◽  
Author(s):  
Claudio Imperatori ◽  
Mariantonietta Fabbricatore ◽  
Benedetto Farina ◽  
Marco Innamorati ◽  
Maria Isabella Quintiliani ◽  
...  

2020 ◽  
Vol 26 (20) ◽  
pp. 2327-2333 ◽  
Author(s):  
Amelia Romei ◽  
Katharina Voigt ◽  
Antonio Verdejo-Garcia

People with Binge Eating Disorder (BED) exhibit heightened sensitivity to rewarding stimuli and elevated activity in reward-related brain regions, including the orbitofrontal cortex (OFC), ventral striatum (VS) and insula, during food-cue exposure. BED has also been associated with altered patterns of functional connectivity during resting-state. Investigating neural connectivity in the absence of task stimuli provides knowledge about baseline communication patterns that may influence the behavioural and cognitive manifestation of BED. Elevated resting-state functional connectivity (rsFC) between reward-related brain regions may contribute to uncontrolled eating bouts observed in BED, through heightened food-cue sensitivity and food-craving. The impact of homeostatic state on rsFC of the reward system has not yet been investigated in people with BED. Homeostatic dysfunction is a key driver of excessive food consumption in obesity, whereby rsFC between rewardrelated brain regions does not attenuate during satiety. Future studies should investigate BED related differences in rsFC within the reward system during hunger and satiety, in order to determine whether individuals with BED display an abnormal neural response to changes in homeostatic state. This knowledge would further enhance current understandings of the mechanisms contributing to BED, potentially implicating both reward and homeostatic dysfunctions as drivers of BED.


Author(s):  
Susan McElroy ◽  
Anna I. Guerdjikova ◽  
Nicole Mori ◽  
Paul E. Keck

This chapter addresses the pharmacotherapy of the eating disorders (EDs). Many persons with EDs receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. This chapter first provides a brief rationale for using medications in the treatment of EDs. It then reviews the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES). It concludes by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.


Author(s):  
Susan L. McElroy ◽  
Anna I. Guerdjikova ◽  
Anne M. O’Melia ◽  
Nicole Mori ◽  
Paul E. Keck

Many persons with eating disorders (EDs) receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. In this chapter, we first provide a brief rationale for using medications in the treatment of EDs. We then review the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa, binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES) and sleep-related eating disorder (SRED). We conclude by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.


Author(s):  
Christopher Hübel ◽  
Mohamed Abdulkadir ◽  
Moritz Herle ◽  
Ruth J. F. Loos ◽  
Gerome Breen ◽  
...  

2006 ◽  
Vol 406 (1-2) ◽  
pp. 133-137 ◽  
Author(s):  
Palmiero Monteleone ◽  
Roberta Zanardini ◽  
Alfonso Tortorella ◽  
Massimo Gennarelli ◽  
Eloisa Castaldo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document